Shares of Sarepta Therapeutics surged Tuesday morning after the company said it had been informed by the Food and Drug Administration that it could resume shipping a drug it paused sales of last week.

This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...

Novo Nordisk tapped Maziar Mike Doustdar, its head of international operations, as its new chief executive officer and ...

Sarepta shares gained even though the U.S. Food and Drug Administration said late Friday that it was probing the death of an ...